Approche diagnostique et thérapeutique de la vasculopathie polypoïdale choroïdienne. Recommandations de la Fédération France Macula.
Angiogenesis Inhibitors
/ therapeutic use
Choroid Diseases
/ complications
Choroidal Neovascularization
/ complications
Diagnostic Techniques, Ophthalmological
/ standards
Fluorescein Angiography
/ methods
France
Humans
Indocyanine Green
Ophthalmology
/ organization & administration
Photochemotherapy
/ methods
Photosensitizing Agents
/ therapeutic use
Polyps
/ complications
Societies, Medical
/ standards
Tomography, Optical Coherence
/ methods
Angiographie au vert d’indocyanine (ICGA)
Anti-VEGF
Indocyanine green angiography (ICGA)
Optical coherence tomography
Optical cohérence tomographie
Photodynamic therapy (PDT)
Photothérapie dynamique (PDT)
Polypoidal Choroidal Vasculopathy
Vasculopathie polypoïdale
Journal
Journal francais d'ophtalmologie
ISSN: 1773-0597
Titre abrégé: J Fr Ophtalmol
Pays: France
ID NLM: 7804128
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
16
12
2018
revised:
25
04
2019
accepted:
02
05
2019
pubmed:
9
6
2019
medline:
29
1
2020
entrez:
9
6
2019
Statut:
ppublish
Résumé
To update the medical literature on the diagnostic and therapeutic approach to polypoidal choroidal vasculopathy (PCV) and to propose a treatment algorithm in agreement with French market approval, supported by the France Macula Federation (FFM). Literature review and expert opinion. The diagnosis of PCV is based on multimodal imaging, including indocyanine green angiography (ICGA), which is considered the gold standard for the diagnosis of PCV. Regarding the therapeutic management of PCV, the FFM recommends treating PCV first-line either by monotherapy with intra-vitreal anti-vascular endothelial growth factor (anti-VEGF) injections, or by a combined treatment of photodynamic therapy (PDT) with Verteporfin and intra-vitreal anti-VEGF injections, depending on the location of the PCV.
Identifiants
pubmed: 31174880
pii: S0181-5512(19)30268-2
doi: 10.1016/j.jfo.2019.05.002
pii:
doi:
Substances chimiques
Angiogenesis Inhibitors
0
Photosensitizing Agents
0
Indocyanine Green
IX6J1063HV
Types de publication
Journal Article
Practice Guideline
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
762-777Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.